A Unified Theory of Two-Stage Adaptive Designs von Liu, Qing, Proschan, Michael A, Pledger, Gordon W

Volltext

Phase 2 and 3 Combination Designs to Accelerate Drug Development von Liu, Qing, Pledger, Gordon W

Volltext

The Value of the Number‐Needed‐to‐Treat Method in Antiepileptic Drug Trials von Lesaffre, Emmanuel, Boon, Paul, Pledger, Gordon W.

Volltext

The FDA's Critique of the Anturane Reinfarction Trial von Temple, Robert, Pledger, Gordon W

Volltext

To the Editor von Pledger, Gordon W

Volltext

To the Editor von Pledger, Gordon W

Volltext

Dosage adjustments in response to monitored plasma concentrations: can unblinded staff adhere to objective criteria? von Todd Sahlroot, J., Pledger, Gordon W

Volltext

To the Editor von Pledger, Gordon W

Volltext

To the Editor von Pledger, Gordon W.

Volltext

Intent-to-treat von Pledger, G W

Volltext

Evaluation of antiepileptic drug efficacy : a review of clinical trial design von PLEDGER, G. W, SCHMIDT, D

Volltext

Confidence intervals versus ρ-values for interpretation of clinical trial results: introduction von Pledger, Gordon W.

Volltext

Confidence intervals versus p-values for interpretation of clinical trial results: introduction von Pledger, G W

Volltext

Electronic compliance monitoring in clinical trials: Benefits and risks von Sahlroot, J.Todd, Pledger, Gordon W.

Volltext

Clinical trials of investigational antiepileptic drugs: Monotherapy designs von Pledger, Gordon W., Kramer, Lynn D.

Volltext

Design of an individualized fixed-dose clinical trial to test the antiepileptic efficacy of a plasma flunarizine concentration von Pledger, Gordon W., Treiman, David M.

Volltext